Company intelligence / Profile preview
Animuscure
Suwon-si, South Koreaanimuscure.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
No clinical trial results have been published or reported. The company appears to be in the preclinical or discovery phase, focusing on mechanism-of-action studies and candidate identification for sarcopenia/muscle diseases through both biologic/protein/gene approaches and small molecules via partnerships.
- Therapeutic areas
- Metabolic DisordersNeurology
- Modalities
- ProteinGene therapySmall molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Dongwha Pharmaceutical
Beyond the preview
Go deeper on Animuscure.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Animuscure.